Lilly Shares Drop Amid Earnings Miss, End to Covid Trial

(Bloomberg) -- Eli Lilly shares are down sharply now that regular trading has begun, falling as much as 6.3%. On top of missing estimates, investors appear concerned that the halt of the U.S.-run t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.